FUTURE FOOD SDN. BHD.

Future Foods, Inc. (FFI) is a pioneering company in the functional food and nutritional supplement industry, founded in 1981. The company specializes in designing, manufacturing, and providing cutting-edge raw materials alongside a branded line of products that bridge the best of science and nature. Their portfolio includes innovative offerings such as the CardioBar™, a heart-healthy functional food bar, and they are recognized for launching groundbreaking products including the first cranberry pill equivalent, the first nutritional gummies, and introducing Alpha GPC — a leading nootropic — to the US market.

Future Foods holds a strong position in the areas of immune health, digestive wellness, and cognitive wellbeing, with over 40 years of experience in human applications of bovine colostrum and hyper immune egg antibodies. Their CardioBar™ is rooted in peer-reviewed research published in JAMA and has demonstrated efficacy comparable to statin drugs in lowering cholesterol, without serious side effects. The company also promotes the Portfolio Diet, an evidence-based dietary approach to reducing cholesterol and heart disease risk.

Beyond nutrition, Future Foods has extended its innovation into biotechnology, providing seed capital for a major stem cell manufacturing company whose cells were utilized in an award-winning Stanford medical study on spinal cord injuries. The company has also received FDA approval for stroke treatment trials and ARDS studies, underscoring its commitment to advancing both nutritional and medical science.